These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 21193831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular cloning of the gyrA gene and characterization of its mutation in clinical isolates of quinolone-resistant Edwardsiella tarda.
    Shin SB, Yoo MH, Jeong JB, Kim YM, Chung JK, Huh MD, Komisar JL, Jeong HD.
    Dis Aquat Organ; 2005 Nov 28; 67(3):259-66. PubMed ID: 16408842
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN.
    Microb Drug Resist; 2011 Dec 28; 17(4):551-7. PubMed ID: 21830947
    [Abstract] [Full Text] [Related]

  • 4. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S, Tandon V.
    Int J Antimicrob Agents; 2011 Mar 28; 37(3):253-5. PubMed ID: 21236644
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
    Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, Piddock LJ.
    Antimicrob Agents Chemother; 2004 Oct 28; 48(10):4012-5. PubMed ID: 15388468
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 28; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
    Randall LP, Coldham NG, Woodward MJ.
    J Antimicrob Chemother; 2005 Oct 28; 56(4):619-23. PubMed ID: 16141278
    [Abstract] [Full Text] [Related]

  • 11. Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.
    Nam YS, Cho SY, Yang HY, Park KS, Jang JH, Kim YT, Jeong JW, Suh JT, Lee HJ.
    Int J Antimicrob Agents; 2013 Feb 28; 41(2):126-9. PubMed ID: 23265914
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.
    Kakinuma Y, Maeda Y, Mason C, Goldsmith CE, Coulter WA, Matsuda M, Dooley JS, Lowery CJ, Moore JE.
    Br J Biomed Sci; 2012 Feb 28; 69(3):123-5. PubMed ID: 23057160
    [Abstract] [Full Text] [Related]

  • 13. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS, Yague G, Fisher LM.
    Antimicrob Agents Chemother; 2001 Nov 28; 45(11):3140-7. PubMed ID: 11600369
    [Abstract] [Full Text] [Related]

  • 14. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
    Liu YH, Kuo SC, Lee YT, Chang IC, Yang SP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2012 Apr 28; 45(2):108-12. PubMed ID: 22153765
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May 28; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
    Tamang MD, Nam HM, Kim A, Lee HS, Kim TS, Kim MJ, Jang GC, Jung SC, Lim SK.
    Foodborne Pathog Dis; 2011 Nov 28; 8(11):1199-206. PubMed ID: 21877929
    [Abstract] [Full Text] [Related]

  • 18. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
    Zhou Y, Yu L, Li J, Zhang L, Tong Y, Kan B.
    Int J Antimicrob Agents; 2013 Jul 28; 42(1):72-5. PubMed ID: 23643392
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H, Duan G, Zhu J, Zhang W, Xi Y, Fan Q.
    Int J Antimicrob Agents; 2013 Aug 28; 42(2):173-7. PubMed ID: 23796894
    [Abstract] [Full Text] [Related]

  • 20. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK, Lee YS, Park YK, Kim BS.
    Int J Antimicrob Agents; 2005 Apr 28; 25(4):290-5. PubMed ID: 15784307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.